The genomic lab provides biological sample analysis services that comply with relevant technical guidelines of NMPA, FDA, EMA, and ICH and meet the requirements of GLP specifications. Teddylab has built a world-leading test technology platform, including PCR instruments, fluorescence quantitative PCR instruments, digital PCR instruments, first- and second-generation sequencers, molecular hybridization instruments, etc. to provide testing services of drug safety, biomarkers, subject screening, PK, efficacy evaluation, etc. for non-small cell lung cancer and colorectal cancer in clinical drug trials, breast cancer, lymphoma and other tumor drugs, as well as anti-covid-19/hepatitis B/hepatitis C/RSV/HPV and other antiviral drugs and vaccines, nucleotide analogs, CAR-T and oncolytic viruses and other cell and gene therapy drugs, and to provide evaluation basis for current popular drugs and vaccine registration applications.